IBRX
IMMUNITYBIO (IBRX)
NASDAQ
$7.20+$0.03 (+0.42%)
Price as of Jul 31, 2026 7:59 PM EDT
  • $7.5B
    Market Cap
  • 202.53%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 37
Valuation
IBRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 50
Valuation
IBRX
vs History
vs S&P 500
3-Month Momentum
32.18%
12-Month Momentum
273.98%
3-Month Risk Adjusted Momentum
108.85%
12-Month Risk Adjusted Momentum
265.33%

True Yield

N/A
Valuation
IBRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.16%
Net Debt Paydown Yield
-8.21%

Financial Health Score

Score: 62
Valuation
IBRX
vs History
vs S&P 500
Ohlson's O-Score
-1